FDA Coronavirus (COVID-19) Update: August 6th, 2020
August 6, 2020
Silver Spring, MD – The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA issued its first warning letter to New Life International and its second warning letter to Fishman Chemical of North Carolina, LLC, both of which distribute chloroquine phosphate products intended to treat disease in aquarium fish.
Coronavirus
FDA Coronavirus (COVID-19) Update: June 16th, 2020
June 16, 2020
Silver Spring, MD – The U.S. Food and Drug Administration is continuing to take action in the ongoing response to the COVID-19 Coronavirus pandemic:
Today, FDA revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate donated to the Strategic National Stockpile to be used to treat certain hospitalized patients with COVID-19 Coronavirus when a clinical trial was unavailable, or participation in a clinical trial was not feasible.
Coronavirus
FDA Coronavirus (COVID-19) Update: April 17th, 2020
April 17, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA provided an update on one potential treatment called convalescent plasma and is encouraging those who have recovered from COVID-19 Coronavirus to donate plasma to help others fight this disease. Convalescent plasma is an antibody-rich product made from blood donated by people who have recovered from the disease caused by the virus.
Coronavirus
FDA Coronavirus (COVID-19) Update: April 14th, 2020
April 14, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
Given the anticipated increase in demand for chloroquine phosphate and hydroxychloroquine sulfate, the FDA is taking steps to ensure that adequate supply of these drug products is available for patients.
Coronavirus
